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INTRODUCTION
Osteomalacia is one of the most common osteometabolic 
diseases among the elderly and may be associated with 
osteoporosis.1 It is typically caused by lack of vitamin D 
and is characterized by mineralization deficiency of the 
osteoid matrix in the cortical and trabecular bone, resulting 
in accumulation of osteoid tissue.2 Vitamin D deficiency is 
a pathogenic factor of osteoporosis that can be modified.5, 
9
 The elderly are at particularly high risk for developing 
osteomalacia, which is frequently misdiagnosed.1, 3
SAMPLE AND METHODS
We report the case of a 62-year-old woman who had 
experienced body pains and weakness for two years. She 
had suffered from multiple fractures of the ribs and the 
left clavicle without trauma for two months before she 
was admitted to the hospital. Comorbidities included 
hypertension, diabetes mellitus, hypothyroidism, depression 
and neurological sequelae with left hemiparesis. The 
patient was using levothyroxine, omeprazole, metformin, 
glymepiride, milnacipran, mirtazapine and atenolol. 
Radiography showed fractures of nine costal arches and 
of the left clavicle. Bone scintigraphy revealed multiple 
osteogenic reaction areas, with predominance in the axial 
skeleton (Figure 1). Bone densitometry showed osteoporosis 
with a lumbar spine (L1-L4) T score of -3.1 and a femur 
(neck) T score of -2.8. The laboratory test results showed 
alkaline phosphatase (AP) 491 U/L (RR-ref range < 104 
U/L); parathyroid hormone (PTH) 146 pg/ml (RR 7-62 
pg/ml); total serum calcium 8.5 mg/dl (RR 8.6-10.2 mg/
dl); ionized calcium 4.7 mg/dl (RR 4.6-5.3 mg/dl); serum 
phosphorus 3.6 mg/dl (RR 2.7-4.5 mg/dl); urinary calcium 
42.3 mg/24h (RR 100-320 mg/24h); and urinary phosphate 
397.4 mg/24 h (RR 400-1300 mg/24h). 
These findings led us to hypothesize that the patient had 
osteomalacia. It was decided to perform a trans-iliac bone 
biopsy. The patient was pre-labeled with oral tetracycline 
(20 mg/kg/day for 3 days) administered over two separate 
intervals 10 days apart. 
The biopsy revealed diminished trabecular volume 
(13.3%), increased osteoid surface (82%) and volume (43%), 
and confluent tetracycline labeling (Figure 2); thus, the 
hypothesis was confirmed. Serum 25-OH-vitamin D levels 
were determined to be 11 ng/ml (RR > 40 ng/ml). The patient 
was prescribed calcitriol at 0.75 mg/day and 2 g of calcium 
carbonate to normalize PTH and alkaline phosphatase (AP) 
levels. Body pains and weakness were eventually reduced. 
Over a follow-up period of three years, the patient did not 
have any new fractures. Her bone mineral density improved 
Figure 1 - Bone scintigraphy on patient: multiple areas of osteogenic 
reaction
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by 38% in the lumbar spine (L1-L4 T-score -0.56) and 67.3% 
in the femur (neck T-score -1.21). Laboratory test levels had 
normalized to alkaline phosphatase (AP) 81 U/L (RR-ref 
range < 104 U/L); parathormone (PTH) 53 pg/ml (RR 7-62 
pg/ml); total serum calcium 9.4 mg/dl (RR 8.6-10.2 mg/
dl); ionized calcium 4.9 mg/dl (RR 4.6-5.3 mg/dl); serum 
phosphorus 4.4 mg/dl (RR 2.7-4.5 mg/dl); urinary calcium 
151 mg/24 h (RR 100-320 mg/24 h) and serum 25-OH-
vitamin D 42 ng/ml (RR > 40 ng/ml). At present, the patient 
is using colecalciferol at 1000UI a day with good results.
DISCUSSION
Vitamin D plays a role in bone mineralization and in the 
regulation of circulating calcium. Deficiency of this vitamin 
results in increased parathyroid hormone (PTH) synthesis 
and secretion.5 This secondary hyperparathyroidism 
increases bone turnover, resulting in increased risk of 
fracture.1 Osteomalacia develops when this process is intense 
and chronic and was histologically apparent in 13 to 33% of 
patients with osteoporotic femoral neck fractures.1, 5
Vitamin D deficiency has been implicated in osteoporotic 
pathophysiology of the elderly and can cause muscle 
weakness as well as predisposition to falls and fractures. 
Osteomalacia may be associated with fractures due to 
minimal stress trauma and should be suspected when 
laboratory exams show increased levels of alkaline 
phosphatase (AP) with normal or decreased serum 
calcium and phosphorus, increased PTH (secondary 
hyperparathyroidism), and absence of lithic lesions and 
neoplasic bone disease. In most cases, osteomalacia can be 
diagnosed by assaying for 25-OH-vitamin D,8 which can 
be useful for early detection of the deficiency. Vitamin D3, 
or cholecalciferol, is synthesized in the skin by ultraviolet 
radiation from the sun. In order to become active, it must 
furthermore undergo two hydroxylations in the liver and 
kidneys.5 Low intake, poor absorption, and insufficient 
exposure to the sun can all result in Vitamin D deficiency. 
In some cases, the defect occurs in the receptor, and the 
diagnosis can only be confirmed through bone biopsy, which 
also allows for differentiation between osteomalacia and 
osteoporosis.2 
Cancer and prolonged use of anticonvulsants such 
phenytoin can also cause osteomalacia. The main differential 
diagnosis is osteoporosis, which shows normal results 
on biochemical tests for calcium, phosphorus, AP and 
PTH. Vitamin D deficits among the elderly have been 
reported in several countries,1,3,4,8 even in Brazil, despite 
its tropical location.5 Vitamin D deficiency has been 
implicated in various pathological conditions including 
osteoporosis, muscle weakness and predisposition to falls 
and fractures.4,7,10,11 Epidemiological studies suggest that 
adequate serum concentrations of Vitamin D are related to 
reduced risk of autoimmune diseases, falls,9 and prostate, 
colon, breast and ovarian cancer.6,9 
CONCLUSION 
Vitamin D deficit may cause osteomalacia, which should 
be included in the differential diagnosis for fractures caused 
by minimal trauma. It is suggested that Vitamin D assays 
should be included in routine assessments of the elderly and 
that Vitamin D supplementation should be considered even 
in tropical countries.
Figure 2 - Biopsy of patient - bone trabecula; bone medulla; osteoid matrix. Absence of double tetracycline labeling
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